Insider Selling: Surgery Partners, Inc. (NASDAQ:SGRY) CEO Sells 26,520 Shares of Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CEO Jason Eric Evans sold 26,520 shares of the firm’s stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $25.65, for a total value of $680,238.00. Following the transaction, the chief executive officer now owns 560,698 shares in the company, valued at $14,381,903.70. This represents a 4.52 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Surgery Partners Stock Up 0.7 %

SGRY opened at $25.75 on Wednesday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $35.29. The stock has a market capitalization of $3.27 billion, a P/E ratio of -53.65, a P/E/G ratio of 17.77 and a beta of 2.60. The business has a 50 day simple moving average of $21.88 and a 200-day simple moving average of $26.90.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Surgery Partners’s revenue was up 14.3% compared to the same quarter last year. During the same period last year, the business posted $0.15 EPS. On average, equities analysts anticipate that Surgery Partners, Inc. will post 0.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on SGRY shares. Bank of America began coverage on shares of Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research note on Tuesday, December 3rd. Royal Bank of Canada lowered their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. Finally, Macquarie reaffirmed an “outperform” rating and set a $34.00 price objective on shares of Surgery Partners in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $36.56.

Hedge Funds Weigh In On Surgery Partners

Large investors have recently made changes to their positions in the stock. Pier Capital LLC grew its position in Surgery Partners by 15.9% during the fourth quarter. Pier Capital LLC now owns 382,493 shares of the company’s stock worth $8,097,000 after buying an additional 52,611 shares during the period. Vanguard Group Inc. boosted its stake in shares of Surgery Partners by 2.3% during the 4th quarter. Vanguard Group Inc. now owns 7,618,404 shares of the company’s stock worth $161,282,000 after acquiring an additional 172,271 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Surgery Partners by 22.4% in the 4th quarter. LPL Financial LLC now owns 16,749 shares of the company’s stock worth $355,000 after acquiring an additional 3,062 shares during the period. KLP Kapitalforvaltning AS purchased a new position in Surgery Partners in the 4th quarter valued at approximately $273,000. Finally, Sei Investments Co. raised its holdings in Surgery Partners by 13.9% during the fourth quarter. Sei Investments Co. now owns 43,666 shares of the company’s stock worth $924,000 after purchasing an additional 5,333 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.